Literature DB >> 29549895

The prevalence of lymph node metastasis for pathological T1 esophageal cancer: a retrospective study of 143 cases.

Xiao-Feng Duan1, Peng Tang1, Xiao-Bin Shang1, Hong-Jing Jiang1, Zhen-Tao Yu2.   

Abstract

OBJECTIVE: To evaluate the prevalence, pattern and risk factors of lymph node metastasis (LNM) for pathological T1 (pT1) esophageal cancer (EC).
METHODS: The clinical data of 143 cases of pT1 patients who underwent esophagectomy and lymph node dissection during January 2011 and July 2016 were reviewed, including 120 male patients and 23 female patients with a median age of 60 years. The pattern of LNM was analyzed and the risk factors related to LNM were assessed by logistic regression analysis. The nomogram model was used to estimate the individual risk of lymph node metastasis.
RESULTS: Of 143 patients with T1 tumors, 25 patients had LNM, and the LNM rate was 17.5%. The LNM rate was 8.0% for T1a tumors, and 22.5% for T1b tumors. The logistic regression analysis showed that the depth of tumor infiltration (P < 0.05), tumor size (P < 0.01), tumor location (P < 0.05), and tumor differentiation (P < 0.01) were independent risk factors related to LNM for T1 EC. These four parameters allowed the compilation of a nomogram to estimate the individual risk of LNM. Tumor differentiation (P < 0.05) was an independent risk factor related to LNM for T1a tumors, and tumor size (P < 0.05) and tumor location (P < 0.05) were independent risk factors related to LNM for T1b tumors. Of 25 patients with LNM, one patient had cervical LNM, 15 patients with thoracic LNM, and 17 patients with abdominal LNM. The relatively highest LNM sites were laryngeal recurrent nerve (n = 8), the left gastric artery (n = 8), right and left cardiac (n = 6) and thoracic paraesophageal (n = 5).
CONCLUSIONS: T1 EC has a relatively high LNM rate, and the depth of tumor infiltration, tumor size, tumor location and tumor differentiation are correlated with LNM. The LNM risk and extent must be considered comprehensively in decision-making of a better surgical treatment and lymph node dissection strategy.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Esophageal cancer; Lymph node metastasis; Nomogram; Risk factor; pT1 stage

Mesh:

Year:  2017        PMID: 29549895     DOI: 10.1016/j.suronc.2017.11.002

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  12 in total

1.  Development and validation of a nomogram for preoperative prediction of lymph node metastasis in pathological T1 esophageal squamous cell carcinoma.

Authors:  Ling Chen; Kaiming Peng; Ziyan Han; Shaobin Yu; Zhixin Huang; Hui Xu; Mingqiang Kang
Journal:  Medicine (Baltimore)       Date:  2022-05-20       Impact factor: 1.817

2.  Development and validation of a nomogram to predict overall survival of T1 esophageal squamous cell carcinoma patients with lymph node metastasis.

Authors:  Jia Yu; Wenyu Hu; Nan Yao; Mengzi Sun; Xiaotong Li; Ling Wang; Yixue Yang; Bo Li
Journal:  Transl Oncol       Date:  2021-05-18       Impact factor: 4.243

3.  Failure patterns after adjuvant chemoradiotherapy following endoscopic resection for superficial esophageal squamous cell carcinoma.

Authors:  Toshiki Ikawa; Ryu Ishihara; Koji Konishi; Masahiro Morimoto; Takero Hirata; Naoyuki Kanayama; Sachiko Yamamoto; Noriko Matsuura; Kentaro Wada; Kenji Hayashi; Kazuhiko Ogawa; Teruki Teshima
Journal:  Cancer Med       Date:  2019-06-20       Impact factor: 4.452

4.  Risk factors for lymph node metastasis in T1 esophageal squamous cell carcinoma: A systematic review and meta-analysis.

Authors:  Kai-Yuan Jiang; Heng Huang; Wei-Yang Chen; Hao-Ji Yan; Zhen-Ting Wei; Xiao-Wen Wang; Hao-Xuan Li; Xiang-Yun Zheng; Dong Tian
Journal:  World J Gastroenterol       Date:  2021-02-28       Impact factor: 5.742

5.  A nomogram to predict lymph node metastasis risk for early esophageal squamous cell carcinoma.

Authors:  Xiaofeng Duan; Xiaobin Shang; Jie Yue; Zhao Ma; Chuangui Chen; Peng Tang; Hongjing Jiang; Zhentao Yu
Journal:  BMC Cancer       Date:  2021-04-20       Impact factor: 4.430

6.  Prognostic value of the extent of lymphadenectomy for esophageal cancer-specific survival among T1 patients.

Authors:  Yang Wang; Xiangwei Zhang; Xiufeng Zhang; Jing Liu-Helmersson; Lin Zhang; Wen Xiao; Yuanzhu Jiang; Keke Liu; Shaowei Sang
Journal:  BMC Cancer       Date:  2021-04-14       Impact factor: 4.430

7.  A Population-Based Study: How to Identify High-Risk T1-2 Esophageal Cancer Patients?

Authors:  Yiming Qi; Shuangshuang Wu; Linghui Tao; Guoshu Xu; Jiabin Chen; Zhengquan Feng; Chao Lu; Yanli Wan; Jing Li
Journal:  Front Oncol       Date:  2021-12-13       Impact factor: 6.244

8.  Clinical nomogram for lymph node metastasis in pathological T1 esophageal squamous cell carcinoma: a multicenter retrospective study.

Authors:  Dong Tian; Kai-Yuan Jiang; Heng Huang; Shun-Hai Jian; Yin-Bin Zheng; Xiao-Guang Guo; Hong-Yun Li; Jing-Qiu Zhang; Ke-Xuan Guo; Hong-Ying Wen
Journal:  Ann Transl Med       Date:  2020-03

9.  Sulforaphene induces apoptosis and inhibits the invasion of esophageal cancer cells through MSK2/CREB/Bcl-2 and cadherin pathway in vivo and in vitro.

Authors:  Chengjuan Zhang; Junxia Zhang; Qiong Wu; Benling Xu; Guoguo Jin; Yan Qiao; Simin Zhao; Yang Yang; Jinwen Shang; Xiaofang Li; Kangdong Liu
Journal:  Cancer Cell Int       Date:  2019-12-19       Impact factor: 5.722

10.  A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol.

Authors:  Lin-Rui Gao; Xin Wang; Weiming Han; Wei Deng; Chen Li; Xiaomin Wang; Yidian Zhao; Wenjie Ni; Xiao Chang; Zongmei Zhou; Lei Deng; Wenqing Wang; Wenyang Liu; Jun Liang; Tao Zhang; Nan Bi; Jianyang Wang; Yirui Zhai; Qinfu Feng; Jima Lv; Ling Li; Zefen Xiao
Journal:  BMC Cancer       Date:  2020-09-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.